000623.SZ
000623.SZ
CNE000000719
JLAD
Loading chart...

Company Profile

Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Dunhua, China.

Related stocks

300558.SZ
300558.SZ • China
BETTA
48.43 CNY
3.07B USD 1Y -29.3%
300142.SZ
300142.SZ • China
WALVAX
14.75 CNY
3.53B USD 1Y +26%
002317.SZ
002317.SZ • China
ZHONGSHENGYAOYE
25.49 CNY
3.24B USD 1Y +50.3%
600518.SS
600518.SS • China
KANGMEI PHARMACEUTICAL CO LTD
1.35 CNY
2.79B USD 1Y -33.8%
300199.SZ
300199.SZ • China
HYBIO
23.71 CNY
3.13B USD 1Y +8.6%
688131.SS
688131.SS • China
SHANGHAI HAOYUAN CHEMEXPRESS CO
93.16 CNY
2.97B USD 1Y +9%
2096.HK
2096.HK • China
SIMCERE PHARMA
10.89 HKD
3.56B USD 1Y -13.7%
600329.SS
600329.SS • China
TIANJIN PHARMACEUTICAL DA REN T
35.8 CNY
4.13B USD 1Y -17.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
25.7% p.a.
Max Drawdown (5Y)
-31.7%
Sharpe Ratio (5Y)
-0.07
Beta Factor
0.53
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -55.6% in the extended horizon.
ende